Position | Company | Period |
---|
Suchen
Datum der Benachrichtigung | Datum der Transaktion | K/V Art der Transaktion |
Anz. der Aktien Kurs Wert |
Anzahl der Aktien | Kurs | Gesamtwert | Details | |
---|---|---|---|---|---|---|---|---|
2024-01-25 | 2024-01-23 |
Edgewise Therapeutics Inc
(EWTX)
|
K Kauf |
454.545
+3.3%
11,004.999.995 USD |
454.545 +3.3% | 11,00 | 4.999.995 USD | |
2023-12-29 | 2023-12-28 |
Alpine Immune Sciences Inc
(ALPN)
|
V Verkauf |
139.166
-34.5%
18,322.549.521 USD |
139.166 -34.5% | 18,32 | 2.549.521 USD | |
2023-12-29 | 2023-12-28 |
Alpine Immune Sciences Inc
(ALPN)
|
V Verkauf |
1.195.683
-34.5%
18,3221.904.913 USD |
1.195.683 -34.5% | 18,32 | 21.904.913 USD | |
2023-12-29 | 2023-12-28 |
Alpine Immune Sciences Inc
(ALPN)
|
V Verkauf |
3.128
-0.8%
19,8261.997 USD |
3.128 -0.8% | 19,82 | 61.997 USD | |
2023-12-29 | 2023-12-28 |
Alpine Immune Sciences Inc
(ALPN)
|
V Verkauf |
26.872
-0.8%
19,82532.603 USD |
26.872 -0.8% | 19,82 | 532.603 USD | |
2023-12-29 | 2023-12-27 |
Alpine Immune Sciences Inc
(ALPN)
|
V Verkauf |
18.922
-4.4%
19,96377.683 USD |
18.922 -4.4% | 19,96 | 377.683 USD | |
2023-12-29 | 2023-12-27 |
Alpine Immune Sciences Inc
(ALPN)
|
V Verkauf |
162.576
-4.4%
19,963.245.017 USD |
162.576 -4.4% | 19,96 | 3.245.017 USD | |
2023-08-31 | 2023-08-29 |
Silverback Therapeutics Inc
(SBTX)
|
K Kauf |
500.000
+6.6%
6,203.100.000 USD |
500.000 +6.6% | 6,20 | 3.100.000 USD | |
2022-09-16 | 2022-09-16 |
Edgewise Therapeutics Inc
(EWTX)
|
K Kauf |
484.496
+3.6%
10,324.999.999 USD |
484.496 +3.6% | 10,32 | 4.999.999 USD | |
2022-05-20 | 2022-05-18 |
Edgewise Therapeutics Inc
(EWTX)
|
K Kauf |
138.000
+1.0%
7,21994.980 USD |
138.000 +1.0% | 7,21 | 994.980 USD | |
2021-12-23 | 2021-12-21 |
Janux Therapeutics Inc
(JANX)
|
V Verkauf |
11.100
-4.5%
19,00210.900 USD |
11.100 -4.5% | 19,00 | 210.900 USD | |
2021-12-23 | 2021-12-21 |
Janux Therapeutics Inc
(JANX)
|
V Verkauf |
108.300
-4.5%
19,002.057.700 USD |
108.300 -4.5% | 19,00 | 2.057.700 USD | |
2021-12-17 | 2021-12-16 |
Janux Therapeutics Inc
(JANX)
|
V Verkauf |
36.500
-12.9%
19,07696.055 USD |
36.500 -12.9% | 19,07 | 696.055 USD | |
2021-12-17 | 2021-12-16 |
Janux Therapeutics Inc
(JANX)
|
V Verkauf |
356.800
-12.9%
19,076.804.176 USD |
356.800 -12.9% | 19,07 | 6.804.176 USD | |
2021-06-16 | 2021-06-15 |
Janux Therapeutics Inc
(JANX)
|
K Kauf |
117.650
+71.4%
17,002.000.050 USD |
117.650 +71.4% | 17,00 | 2.000.050 USD | |
2021-06-16 | 2021-06-15 |
Janux Therapeutics Inc
(JANX)
|
K Kauf |
588.203
+27.1%
17,009.999.451 USD |
588.203 +27.1% | 17,00 | 9.999.451 USD | |
2021-02-19 | 2021-02-17 |
Decibel Therapeutics Inc
(DBTX)
|
K Kauf |
555.566
+169.5%
18,0010.000.188 USD |
555.566 +169.5% | 18,00 | 10.000.188 USD | |
2021-02-19 | 2021-02-17 |
Decibel Therapeutics Inc
(DBTX)
|
K Kauf |
1.111.100
+40.7%
18,0019.999.800 USD |
1.111.100 +40.7% | 18,00 | 19.999.800 USD | |
2021-02-19 | 2021-02-17 |
Corvus Pharmaceuticals Inc
(CRVS)
|
K Kauf |
1.285.714
+19.0%
3,504.499.999 USD |
1.285.714 +19.0% | 3,50 | 4.499.999 USD | |
2020-12-30 | 2020-12-28 |
Alpine Immune Sciences Inc
(ALPN)
|
V Verkauf |
600.000
-16.3%
14,258.550.000 USD |
600.000 -16.3% | 14,25 | 8.550.000 USD | |
2020-12-08 | 2020-12-08 |
Silverback Therapeutics Inc
(SBTX)
|
K Kauf |
952.377
+inf%
21,0019.999.917 USD |
952.377 +inf% | 21,00 | 19.999.917 USD | |
2020-12-08 | 2020-12-08 |
Silverback Therapeutics Inc
(SBTX)
|
K Kauf |
238.100
+88.4%
21,005.000.100 USD |
238.100 +88.4% | 21,00 | 5.000.100 USD | |
2020-09-29 | 2020-09-25 |
PMV Pharmaceuticals Inc
(PMVP)
|
K Kauf |
475.000
+inf%
18,008.550.000 USD |
475.000 +inf% | 18,00 | 8.550.000 USD | |
2020-09-29 | 2020-09-25 |
PMV Pharmaceuticals Inc
(PMVP)
|
K Kauf |
475.000
+inf%
18,008.550.000 USD |
475.000 +inf% | 18,00 | 8.550.000 USD | |
2019-07-01 | 2019-07-01 |
Corvus Pharmaceuticals Inc
(CRVS)
|
K Kauf |
59.243
+0.9%
3,91231.640 USD |
59.243 +0.9% | 3,91 | 231.640 USD | |
2019-07-01 | 2019-06-28 |
Corvus Pharmaceuticals Inc
(CRVS)
|
K Kauf |
565.178
+9.4%
3,722.102.462 USD |
565.178 +9.4% | 3,72 | 2.102.462 USD | |
2019-07-01 | 2019-06-27 |
Corvus Pharmaceuticals Inc
(CRVS)
|
K Kauf |
32.923
+0.6%
3,34109.963 USD |
32.923 +0.6% | 3,34 | 109.963 USD | |
2019-06-26 | 2019-06-24 |
Prevail Therapeutics Inc
(PRVL)
|
K Kauf |
882.352
+6.8%
17,0014.999.984 USD |
882.352 +6.8% | 17,00 | 14.999.984 USD | |
2019-01-23 | 2019-01-18 |
Alpine Immune Sciences Inc
(ALPN)
|
K Kauf |
372.439
+11.3%
5,371.999.997 USD |
372.439 +11.3% | 5,37 | 1.999.997 USD |